Paul Samuels highlights challenges and progress in treating opioid dependence, suggesting ongoing stigma impacts success.
Whenever things look dim, people like Paul Samuels look back to what they were like decades ago. “The predominant idea across the country was that people with substance use disorder were bad people, somehow deformed defectives who had a moral weakness,” the president and director of the Legal Action Center (LAC) told attendees at the American Association for the Treatment of Opioid Dependence (AATOD) meeting in Philadelphia this month.
No takes yet. Share an insight, caveat, or question.
Alison Knopf (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: